Drug Profile
Rabies vaccine - Bavarian Nordic
Alternative Names: KD-357; Purified chicken-embryo cell rabies vaccine; RabAvert; Rabipur; Rabivac; RasilvaxLatest Information Update: 25 Sep 2021
Price :
$50
*
At a glance
- Originator Novartis
- Developer GSK; KM Biologics; Sanofi
- Class Viral vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Marketed Rabies
Most Recent Events
- 18 Jun 2020 Bavarian Nordic and Valneva SE enters into an agreement for the marketing and distribution of rabies caccine in Germany, Switzerland, Canada and USA
- 31 Dec 2019 GlaxoSmithKline (GSK) completes divestiture of rabies vaccine to
- 22 Oct 2019 Bavarian Nordic enters into a purchase agreement with GlaxoSmithKline (GSK) to purchase Rabies vaccine (Rabipur)